Podcasts about factors

Return to Work After Stroke: How Marco Calabi Rebuilt His Career, His Purpose, and His Life At 47 years old, Marco Calabi was a DevOps engineer living in Italy – someone who spent his days automating systems, solving complex problems, and helping companies stop wasting time on repetitive tasks. He was healthy, working, paying bills, and spending time with friends. Life was normal. Then, without warning, everything changed. A small hole between the two chambers of Marco’s heart, a condition known as Patent Foramen Ovale, or PFO, had allowed blood flows to mix. A clot formed. It travelled to his brain. By the time his partner and sister realised something was terribly wrong, Marco was moving his arm involuntarily, unaware of what was happening to his own body. The emergency services were called twice. The second time, they came. Marco underwent eight hours of brain surgery. He was placed in a medically induced coma to allow his brain to rest. When he finally opened his eyes, he was on a hospital bed, and the road back had only just begun. The Reality of Stroke at 47 Marco woke from surgery to find the right side of his body had been affected. His arm, hand, and leg were weak. His speech was impaired. He left the hospital in a wheelchair. For many stroke survivors, this is the moment that defines everything that follows, not the stroke itself, but the first honest look at what recovery is actually going to require. “In the beginning, I was helped in everything,” Marco recalls. “They prepared my lunch. They helped me go to the bathroom. My family never left me alone.” His mother, his partner, his sister, and a close friend in the Netherlands all rallied around him. At home, physiotherapists and local health professionals visited him directly, a level of care he describes as incredible. Step by step, he began to reclaim his independence. First, the bathroom. Then the kitchen. Then the stairs. Each small act of autonomy arrived with a feeling he hadn’t expected: power. “You feel good because you think you have power again,” he says. “It is a very important moment.” Return to Work After Stroke: Why It Matters For working-age stroke survivors, the question of whether they can return to work after stroke is one of the most pressing they face. Identity, purpose, financial security, and routine work carry all of these things, and a stroke threatens all of them at once. For Marco, returning to work wasn’t just a financial necessity. It was evidence that his life still had forward momentum. He went back to his role as a DevOps and Site Reliability Engineer, initially working six hours a day instead of eight. The work itself, automating processes and improving systems, remained the same. Only the pace had changed. “I do the same things, but with different speeds,” he says simply. That shift in pace is something many stroke survivors recognise. Recovery doesn’t demand perfection. It demands persistence. “The right moment is now. Not after, not tomorrow, not next week. Now.” — Marco Calabi Recovery Happens in Steps One of the most grounded things Marco shares is this: recovery cannot be rushed. “The experience is made of steps,” he says. “You must live every step. The first steps are physical. And then your mind changes. But you must let yourself be.” This is the part that rarely gets talked about openly. The pressure to recover quickly — to prove to yourself, your family, and your employer that you are still capable — can work against the very process you are trying to complete. Marco’s advice is to resist the urge to skip ahead. Physical recovery comes first. Mental and emotional transformation follows naturally from there. Trying to rush past the physical phase doesn’t speed up recovery. It disrupts it. The Book, the Purpose, and the Shift Deep into his recovery, Marco did something unexpected. He wrote a book. Cambio di Vita, translated into English as Life Change: To Hell and Back, is his account of what happened, what he felt, and what he learned. Available on Amazon in digital and paperback. Writing started as a personal exercise. Somewhere in the process, its purpose shifted. “I said, my story is useless in this moment. I can make something,” Marco explains. “And so the book has another meaning to share.” For a man who had always found purpose through his career, the stroke opened an unexpected door. Helping others became a new calling. Speaking engagements, podcasts, and community conversations, Marco has built a new layer of meaning onto the life he already had. His best friend told him he had become wiser. His own reflection on what changed is striking: “Heartlessness is useless. You reach the hearts of people with softness.” What Stroke Taught Him About Life Perhaps the most powerful thing about Marco’s story is not what he lost, but what he found. He found that the right moment is always now, not when conditions are perfect, not when recovery is complete, but right now, with whatever capacity you currently have. He found that family and friends matter more than most of us acknowledge until we truly need them. He found that purpose doesn’t require a perfect body or a full working week. It requires a decision. If you are navigating life after stroke, wondering whether you can return to work, rebuild your identity, or find meaning in what remains, Marco’s story is proof that it is possible. Not easy. Not fast. But absolutely possible. If you are rebuilding your life after stroke and want a guide for the journey ahead, Bill’s book The Unexpected Way That a Brain Injury Can Change Your Life is waiting for you at recoveryafterstroke.com/book. If this podcast has supported you, consider supporting it back at Patreon. Your contribution keeps this community growing. FAQ: Return to Work After Stroke Can you return to work after a stroke? Yes, many stroke survivors do return to work, though the timeline and capacity vary depending on the severity of the stroke, the type of work, and individual recovery. Marco Calabi returned to his role as a DevOps engineer, initially working six hours a day instead of eight. The key is a gradual, supported transition. How long does it take to return to work after a stroke? Recovery timelines vary widely. Some survivors return within weeks; others need months or years. Factors include the type and severity of stroke, the physical and cognitive demands of the job, and the quality of rehabilitation support. There is no universal timeline. Patience and persistence matter more than speed. What can I expect when returning to work after a stroke? Many survivors return at reduced hours or modified duties. Adjustments to pace, task complexity, or physical demands are common. Open communication with employers and occupational therapists can help structure a gradual, sustainable return. Marco worked six-hour days and describes it simply: “I do the same things, but with different speeds.” Does returning to work help stroke recovery? For many survivors, returning to work contributes positively to recovery, providing routine, purpose, social connection, and a sense of forward momentum. Marco Calabi describes his return to work as evidence that life still had forward momentum. However, the timing must be right, and the transition should be gradual. What if I can’t return to my previous job after a stroke? Some survivors find that stroke opens doors to new kinds of purpose volunteering, writing, advocacy, or a different career direction. Marco Calabi used his recovery to write a book and speak to others about life after stroke. The key is finding what gives you meaning, even if it looks different from before. For more guidance on rebuilding life after stroke, visit recoveryafterstroke.com/book. This blog is for informational purposes only and does not constitute medical advice. Please consult your doctor before making any changes to your health or recovery plan. Marco Calabi — From Induced Coma to Back at Work: A Stroke Survivor's Honest Recovery Story At 47, Marco Calabi had a stroke caused by a hole in his heart. Today he's back at work, has written a book, and is helping others go on. Marco’s Facebook Marco’s Instagram Marco’s Book: Life Change Highlights: 00:00 Introduction: Return to Work After Stroke 02:27 Life Before and After the Stroke 05:23 Health Awareness and Stroke Causes 09:22 The Day of the Stroke 15:02 Writing the book “Life Change: To Hell and Back” 27:51 The Importance of Support During Recovery 33:15 Gaining Autonomy and Finding Purpose 39:14 The Power of Mindset in Recovery 43:24 Life Lessons Learned Post-Stroke 47:24 Inspiring Others Through Personal Experience Transcript: Introduction: Return to Work After Stroke Bill Gasiamis (00:00) what kind of things is okay to complain about? Like in Italy, if the pasta is not cooked al dente, you must complain. Marco Calabi (00:07) Okay, yeah. Okay, yes, yes. Bill Gasiamis (00:08) you Marco Calabi (00:13) Okay, but you complain, you learn to complain about very important things. Bill Gasiamis (00:24) Hello everyone and welcome to the recovery after stroke podcast. Before we get into today’s episode, I want to tell you about a tool I’ve been using and genuinely love turn to.ai. If you’ve ever tried to keep up with the latest stroke research, you’ll know how overwhelming it can be. There are literally 800 new things published every single week about stroke research papers, patient discussions, expert comments, clinical trials, events. Nobody has time to read all of that. Turn2.ai is an AI health sidekick that does it for you. It searches everything published in the past week and sends you what’s most relevant to your situation personalized every week straight to you. It’s my favorite new tool for 2026. It’s just $2 a week, patient first, low cost. And here’s what I love about this. When you sign up through my link, you’re supporting this podcast at absolutely no extra cost to you. Use code Bill10 for 10 % off and try it free at the link below or scan the QR code on your screen. Speaking of resources, if you’re rebuilding your life after stroke and want a roadmap for what comes next, my book, The Unexpected Way That a Stroke Became the Best Thing to Happen is available at recoveryafterstroke.com/book. It’s written from experience, my own and other stroke survivors. And I hope it helps you the way writing it helped me. And to everyone supporting the show Patreon, thank you genuinely. This is not possible without you. Now today’s guest is Marco Calabi, a DevOps engineer from Italy who had a stroke at 47 caused by a hole in his heart. He went through eight hours of brain surgery, wake up from a medically induced coma, left hospital in a wheelchair and went on to return to work, write a book, and find a new sense of purpose. This is a remarkable conversation. Let’s get into it. Bill Gasiamis (02:18) Marco Calabi welcome to the podcast Marco Calabi (02:21) Yes, I’m ready and thank you for your invitation. Life Before and After the Stroke Bill Gasiamis (02:27) Tell me a little bit about what your life was like before you had the stroke. Marco Calabi (02:33) Yes, before my stroke, my life was normal, I say. Working, paying bills, going outside with friends and so on. After the stroke, everything changed because… Bill Gasiamis (02:53) Yeah. Did you have a, what kind of work did you do before the stroke? Marco Calabi (02:58) Before the stroke, even after the stroke, I work ⁓ in computer science field. I’m a DevOps engineer. And after the stroke, I work a little less. Six hours, I can do eight hours before the stroke. But I do the same things. I do normal things. project something about I’m very, very, very vertical in this moment. I work in a site, the reliability engineer field. my aim is to help this system to service. to automate things. And I’m like a robot. I like a robot. Bill Gasiamis (04:05) to automate. To automate things. So, okay, to automate manual processes or something like that. Marco Calabi (04:10) ⁓ so pretty. Yes, yes, I try to automate everything because the people, the company now try to avoid to make the people to repeating things. because you want people… make more important things and the repeating things are not very important. in my opinion, diminishing view of the work. And I try to make the things better in some way. before the soak and even after the soak. I do the same things but with different speeds. Health Awareness and Stroke Causes Bill Gasiamis (05:23) Yeah. With you regards to your health, how did you view your health before the stroke? Did you think you were healthy? Did you think you were well, or was there some things that you were dealing with that were related to the stroke that occurred? Marco Calabi (05:38) Yes, before the stroke I was healthy, but I was very worried about my health because I found a lot of health problems in my body, but the problems were not there. because after the stroke, I did understand I was healthy in that moment. And the stroke teached me to understand my health better. yes, yes, yes. Bill Gasiamis (06:30) You were heavy? Marco Calabi (06:37) because I went out from the hospital with wheelchair. And now I’m able to walk. Bill Gasiamis (06:51) Aha. So were you overweight? Marco Calabi (06:56) No, no, I’m not. I had a stroke maybe because the doctors doesn’t know the motive. Perhaps, perhaps it was a genetic problem in my heart because of FOP, because a small all between the two chambers in my heart. And the mixing of the two flow bloods makes problems to the brain. And after the stroke, ⁓ the stroke happened. But I… Bill Gasiamis (07:51) Yeah, did they? Did they find a hole in your heart? Marco Calabi (07:55) Yes, yes, and I was operated in my heart. Closing, yes, closing the hole because people suffer this common problem. But sometimes the problem is huge. A lot of people… Bill Gasiamis (08:01) to fix the hull. ⁓ huh. Hmm. Marco Calabi (08:25) don’t suffer major problems. But sometimes it is very, very important. In my case, was very, very important because it created the mixing of the blood flows, created ⁓ a blood costrain. to the brain and the platypus brain ⁓ created a stroke. It is the opinion of the doctors. Bill Gasiamis (09:04) on the How old were you at the time? Marco Calabi (09:10) I softened the stroke at 47 and now I’m 51 years old. Yes. The Day of the Stroke Bill Gasiamis (09:22) 41, 47 when the stroke happened. On the day of the stroke, did you notice there was some, something wrong? Did you feel strange, feel different? Marco Calabi (09:31) Yes, during the stroke it was terrible because I did a lot. My mate called the emergency number and they thought it was a problem of annotation. the neck. And my sister, because my brother called my sister, and my sister came into my house and she understood something was wrong, because I moved my arm in the air. Bill Gasiamis (10:02) Mm-hmm. Marco Calabi (10:30) And I had, sorry, because remembering these things makes me a little uncomfortable. yes, but okay. And my sister, together with my mate, decided to call again the Belgics. and then they went to buy house and my story began. Bill Gasiamis (11:14) Hmm. So I’m going to go back for a moment and ask you about what just happened. You got uncomfortable. it emotional to talk about what happened to you sometimes? Marco Calabi (11:23) Yes, yes, yes, because I know I never accepted this thing I’m living together with it but yes, because yes, yes, because I think Bill Gasiamis (11:42) Uh-huh. You haven’t accepted it yet. Marco Calabi (11:52) I will never accept this thing. But I try to go on. I try. Bill Gasiamis (12:01) Why? Why do you think you won’t accept it? And is that helpful to not accept it? Marco Calabi (12:08) Because it is very hard to accept. Because it is not normal, in my opinion, to accept the bad things in life. ⁓ We must live together with them. Because… because we must live and stop. But living gains understanding is very different. Yes. Bill Gasiamis (12:48) If you’ve chosen to live with it and overcome the challenges that it gives, isn’t that a form of acceptance? Marco Calabi (12:58) Maybe. is, in my opinion, it is a form of acceptance. Because sooner or later I make something, I do something. And my father said it is useless to look through the ceiling. And it is a big truth. It is useless. Your life is in your hands. And you in that moment, your life is a lot in your hands. And you must decide your future because No people are able to help you. No other people, friends, family, relatives, and so on. You must do only with your strength and soul. Bill Gasiamis (14:18) Yeah. And to me, that sounds like acceptance. You have taken responsibility for the ⁓ recovery that you have to do. You’ve taken responsibility for your life. You’ve made steps to rehabilitate yourself, your emotions, your mental health. You wrote a book about what happened to you. And that sounds like you have accepted a lot of what happened to you, even though perhaps what it sounds like you’re saying maybe, and you can correct me if I’m wrong, it sounds like you’re saying, ⁓ I’m not going to give up. Writing the book “Life Change: To Hell and Back” Marco Calabi (15:02) Yes, yes, because I wrote a book because I followed a possible path because it was a path of recovering not only physical recovering but mainly mental recovery and writing the book was very helpful for me. And I hope it is helpful for others. Because in the beginning, I wrote the book because I tried to tell my story. And then I said, my story is useless. in this moment. I can make something. And so the book has another meaning. And because I want in this way to help, to share, to share. It is the right word. to share my experience. Not to… to share. To share. Bill Gasiamis (16:36) Yeah. Life change to hell and back is the English title, but you wrote the book in Italian and then had it translated to English. Correct. Marco Calabi (16:45) Yes, yes. In Italian, it is called Cambio di Vita. And in English, is ⁓ called Life Change. And to hell and back is the subtitle, because I went to tell. it was an help for me and perhaps I come back to tell to share to the others what I saw and what I did feel and I hope this experience will help in some way other people. Bill Gasiamis (17:17) Mm-hmm. Understand. Your journey started after the second time the emergency services were called to your house. What happened after that? Did they come to your house and then they took you to hospital? Did they treat you at your house? What happened? Marco Calabi (17:59) No, no, the physiotherapist and the therapist went to my house because I was not able to go to the hospital again. And then Italian hospitals decided to come directly. to my house and help me in my house. And so physiotherapists and local beauties, they were incredible. They were very, very professional and very, very helpful for me. Helped me to recover a little my body. in my speech. Bill Gasiamis (18:59) Before the recovery, I just wanted to understand what happened when you were having the stroke, the day of the stroke. your sister called the emergency services a second time. Did they take you to hospital to understand what was wrong? Marco Calabi (19:14) Yes. Yes, and I was operated immediately because my brain started to grow. And then I was operated because they didn’t want to… Bill Gasiamis (19:23) huh. Expand. Marco Calabi (19:47) to have to experience later problems. And they operated to me for eight hours. And then I was inducted with a comma. because my brain needed to rest. And then I woke up on a bed looking around and seeing people. And I remember I remembered a woman said, it is time to walk. And with a lot of difficulty, I started to walk. And then I was transferred to another hospital. to specialize ⁓ in stroke recovering. And there I was there for two months. Bill Gasiamis (21:10) Mm-hmm. And what were the deficits you needed to get rehabilitated from? Did you have problems with your body, with your limbs, with your, what was the problem? Marco Calabi (21:27) Problems with the walk, problems with the speaker. a problem to it because I was, I don’t know, it is visible. Yes, yes, because during the search they opened a hole. ⁓ Bill Gasiamis (21:47) ⁓ trick you trick you asked me Marco Calabi (22:05) And then the wall remains open for all of that time. And then I was eliminated from this wall. And one month later, the wall was… All was closed. Bill Gasiamis (22:36) Okay, so you had the chocostomy in for a long time and ⁓ they removed the chocostomy, then the hole is there, takes a month to close. Marco Calabi (22:39) Yes. Yes. Yes, yes, yes. And my mate says it seems a cross. I don’t know, I don’t. Okay, Why not? Bill Gasiamis (22:56) It seems across. ⁓ Why not? Yeah. So, so you had to also learn to walk again, which side of your body was impacted by the stroke, which one was it your left side or your right side that didn’t work. Marco Calabi (23:14) my right side my right side my leg my arms my arms my hands and okay all the right side and ⁓ i am weaker to the right side and okay Bill Gasiamis (23:16) Mm-hmm. Waker. Marco Calabi (23:38) In the beginning, I was not able to write. And then after a long, very long training, I am able to write again. Very, very slowly, but I am able. Bill Gasiamis (24:00) Mm hmm. And when you were in hospital, what was the hardest part of the recovery for you? Did you, when you started walking again, what was that like? Marco Calabi (24:14) In the hospital, never stop, always on the wheelchair. And I stop when I come back home. But yes. No, no, no, no. Bill Gasiamis (24:38) You stood up when you came back home, but in rehabilitation, you didn’t stand up. Marco Calabi (24:44) very very sad. very very sad. ⁓ Above all in the transportation for example from the wheelchair to the bed or do an exercise bicycle maybe but stop stop stop. ⁓ I remembered sometimes they tried to make me walk on the stairs, very, very, very few stairs, and tried to make ⁓ me walk in corridors and stuff. Bill Gasiamis (25:48) Okay and your arm, your right arm, you couldn’t use it at the shoulder and the hand, is that what the problem was? Marco Calabi (25:58) Yeah, I can use it. I can use it. It is weaker. A little weaker. But I can use it in this moment. When I was in the hospital, my right arm had problems. Because ⁓ the mobility was limited. And after two months, I was able to move it freely. And now I’m able to move it again in every direction. Bill Gasiamis (26:49) Hmm. ⁓ Very good. When you came home from hospital, who was at home with you? Were you living alone or did you have some family with you? Marco Calabi (26:58) No, no, no, with my family, with my sister and with my mate because my sister and my mate never leave me alone. Leave me alone. they encouraged me. Thanks God because… ⁓ I think in this moment, family, friends, relatives, mates are very, very important. Above all, in this moment. Bill Gasiamis (27:44) Was there somebody that helped guide you through the recovery? Someone that stepped up and you had a lot of support from? The Importance of Support During Recovery Marco Calabi (27:51) My Yes, my friends. Above all, one of my friends who lives in the Netherlands because he was very worried about my health. And my bait talked to him to synchronize him about my condition and after and when I went back home he was very very very present and he was very very he was a very good friend. Bill Gasiamis (28:52) understand. So he came, supported you, was very present when you came back home. Yeah. Marco Calabi (29:00) Yes, yes, yes. Above all, my mom, my sister, my baby, obviously, my friends. Because in this moment, it is a moment you understand very well the friends. more close in the friends maybe, ⁓ maybe are fearful of your situation. Bill Gasiamis (29:44) Yes, yes, very much. Lots of people get fearful ⁓ when somebody they know how to stroke, they don’t know how to help and what to do. Marco Calabi (29:53) Yes, because I think it is natural. I understand it is natural because the first thing a friend, a person who knows you in things is what I can do. And she is very fearful because the situation is huge. And I understand in this moment, in that moment, you understand very well the people. And you understand very well the quality. Bill Gasiamis (30:39) Yes. Marco Calabi (30:46) Yes, you are the same. You are the same. Bill Gasiamis (30:47) your friends. Yeah, very common, very common. Doesn’t matter if you live in Italy, America, Australia, experience is very similar. People have very similar ⁓ reporting about friendships. Marco Calabi (30:59) Yes, I don’t think it is different from country to country because we are human being and stop and and stop. ⁓ Bill Gasiamis (31:08) you People are people. What kind of things did you need help with at home? Could you go to the bathroom on your own? Could you eat on your own? What help was your family providing you? Marco Calabi (31:28) Yes, in the beginning I was helped in everything because they prepared my lunch, ⁓ they helped me to go to the bathroom, they face outside the door, checking the situation. Okay, okay, okay. I understand, okay. And then, with time, I conquered my autonomy. Because, for example, going to the bathroom, cooking something. Bill Gasiamis (31:58) Thank God. Thanks a lot. Marco Calabi (32:22) and doing my pet and so on. It is very important because in these moments you say to yourself, I’m able again. My life is not useless. It is silly to say. I know. It is very, very silly to say. But… Bill Gasiamis (32:54) in the moment, it’s probably okay in the moment, but now on reflection, it’s silly to say that, but at the moment it’s difficult and it’s a emotional experience and it’s a relief that you have and you have some autonomy now again, and you feel good about it. So yeah. Gaining Autonomy and Finding Purpose Marco Calabi (33:01) Yes. Yes. Yes. Yes, yes, you feel good because you think you have a power again. I don’t know. And it is a moment. It is a very important moment for you. I understand. I understand the luckiness. able to know because other people ⁓ has no luck ⁓ like me. Like me. And I understand. And this thing makes me run because, OK, I’m lucky and so I want Bill Gasiamis (33:55) Mm-hmm. Marco Calabi (34:11) I want to help others because I’m black. And so. Bill Gasiamis (34:16) Yes, have luck. You have a bit of luck on your side. You are improving. You’re getting better. You have autonomy. Again, you want to help other people because it’s important. Marco Calabi (34:25) Yes, very. In my opinion, it is very, very important because life otherwise is meaningless. you have to give some meaning to your life. And the stroke in some way helped me to discover my possible goal in my life. Bill Gasiamis (34:44) Yeah. calling in life, understand. So you didn’t get married, you didn’t have a family. Marco Calabi (35:09) No, I never married, but I have made a girlfriend for, I don’t know, 11, 12 years. We are like married. No, no, no, no. Bill Gasiamis (35:28) Okay, but you didn’t have children. Okay. So for you made a good point about purpose and meaning in life and helping other people. If you’re, if you don’t have family to, ⁓ fuss over to ⁓ to help out, to support, et cetera, when they’re young, like children, it could be a little bit of a gap in your life about purpose and meaning. And now that you had the stroke, you found that supporting other people provides you with some additional purpose and meaning above your relationship as well with your partner. Marco Calabi (35:50) Yes. Yes. Yes, because not ⁓ having keys makes me available, let me see, help others who have keys and maybe ⁓ they are busy, too busy. Bill Gasiamis (36:22) Yeah. Marco Calabi (36:35) for other things and I try to make ⁓ my life helpful for those ones. Bill Gasiamis (36:46) Yeah, you have more spare time and you can allocate that to helping other people. Yeah. So, you know, the Marco Calabi (36:50) Yes, yes, yes, yes. Bill Gasiamis (36:59) You talk very positively about your recovery. You’re focusing on all the positive things. You wrote a book. You want to help other people. But was there some times that you really struggled, that you had a really hard time and you needed more support emotionally or mentally? Marco Calabi (37:18) both of things. I had ⁓ moments with a lot of climate. Bill Gasiamis (37:21) Both. crying, yeah, very common. Marco Calabi (37:32) because ⁓ in those moments I was ⁓ I saw my life had problems. And for example, my mother’s teach me again ⁓ to wake on the shoes. And so in that moment, I… was I was ⁓ I… ⁓ I understood my situation very deeply. And why I wanted to prove it? Because every day I wanted to go on and every day I wanted to progress because I don’t want to live was moments again. I would like to make my life better. Bill Gasiamis (39:06) Uh-huh. Understand. Yeah. But it was difficult to make your life better because you’re just in the recovery phase. You’re very restricted. Things are difficult. The Power of Mindset in Recovery Marco Calabi (39:14) Yes. It is very, very, important the presence of your family, of your friends, because otherwise I would not be here. ⁓ Bill Gasiamis (39:40) Yeah, that helped to bring you back. Marco Calabi (39:41) Yes, yes. And then after their help, you must help yourself. Because I understand, I understand you have everything to complain, but complaining is useless. It’s useless. Bill Gasiamis (39:54) as well. Marco Calabi (40:09) Complaining is natural, but it must be very short. A moment of self-reflection, a moment and stop. And then you must do something for yourself and stop. Stop to look to the ceiling. This useless. I wanted to say this useless. Bill Gasiamis (40:45) Yeah, I agree. But it’s something we all do. We all find ourselves complaining about our situation, but as long as you don’t stay there for a long amount of time, you can do the complaint and then move on and continue looking at things that you… Marco Calabi (40:57) Hmm. Hmm. Yes, Complaining is not a part, it’s a mainly part of my spirit. I complain ⁓ very, very few times. I understand people are different and the complaining is different, but… You must very, very, very aware of your situation and this stroke maybe makes you aware, more aware about yourself, about your problems, about your weakness and starting, starting, I interline, starting. from that you can go on. Bill Gasiamis (42:04) You can go on. Yeah, I agree. When you complain about things, like what kind of things is okay to complain about? Like in Italy, if the pasta is not cooked al dente, you must complain. Marco Calabi (42:23) Okay, yeah. Okay, yes, yes. Bill Gasiamis (42:24) you It’s important. You have to tell the chef, I’m sorry, the pasta is not al dente. You have to take it back. Marco Calabi (42:35) Okay, but you complain, you learn to complain about very important things. Yes. Bill Gasiamis (42:46) Yes, it’s feedback. It’s not complaining. It’s feedback. My food is not al dente and I need you to make it again so I can eat it because I can’t eat like this. It’s too cooked. Marco Calabi (42:51) What? I never was, I never liked a very, very precious food and I ate everything. I tasted everything, I ate everything. Even in the hospital, I ate everything. Life Lessons Learned Post-Stroke Bill Gasiamis (43:24) Is Italian hospital food good or is it terrible? Marco Calabi (43:31) It is a hospital book. And so it is very light. It is very, very, very simple. And it is very teachable. it is not a good book. Bill Gasiamis (43:43) Yeah. Yeah. You spoke a little bit earlier about how you have to go on with your life. So looking back now, how have you changed the way that you go about your life? How do you do things differently now? Marco Calabi (44:15) everything, everything, everything. I looked at the life in different way because I put the things in different priorities, working, having good time with friends and so on. Because before stroke you… to think about the things you do every day, but you don’t do that. Those ones. Then after the stroke, you start to do immediately the things. You don’t want to wait for things, the right moment and stop. Because the right moment, you understand, is now, not after, not tomorrow, not the next week. Now, it is a new way of singing life. You stop to wake because you understand time is very very precious. Bill Gasiamis (45:50) Yeah, and we may not have tomorrow. Understand. Marco Calabi (45:53) Yes, yes, you must do the things now and stop. As you can. You must not be a Superman. You must not do ⁓ things, a lot of things. You must do what you can and stop. But you must do. Bill Gasiamis (46:24) Yeah. Marco Calabi (46:25) and stop. Not tomorrow, not in one week, and not in one month. Now. You must do now. And stop. Never you understand, never stop you. Bill Gasiamis (46:47) Yeah, I agree. Once you have a stroke, you realize that you are mortal and that maybe you don’t have… Marco Calabi (46:53) It’s just… Bill Gasiamis (46:58) another 50 years or 40 years ahead of you. maybe you need to do, take more action, do more things, have the experiences you want to experience, whatever you can, I agree. ⁓ It’s something I think that is a good way to inspire people who have had a stroke, who have injuries, that you can find a way to do something that you want to do that you haven’t done. Inspiring Others Through Personal Experience Marco Calabi (47:24) Yes. Bill Gasiamis (47:24) that you love. very important to try and get it done, find a way to make it happen. Even if you’re in a wheelchair, even if it’s difficult, even if you need a lot of planning, you know, has to be something that you tick, you tick off your list of things to do. Marco Calabi (47:42) And it is not important what type of disease you suffer, cancer, stroke, leukemia, so on. It is, in my opinion, very important your mind, the way your mind, the way… Bill Gasiamis (48:10) your minds. Marco Calabi (48:10) want you, your mindset, the way you want to go on and stop. But I want, I want, I want to tell my story. Maybe, tell. If I am able to go on, everyone is able to go on. Bill Gasiamis (48:19) Yeah. Marco Calabi (48:41) It is not something special. Everyone can go to work and so Bill Gasiamis (48:51) Yeah, I agree. Everyone should go on with their life in some capacity as much as they can. ⁓ Yeah, that’s excellent. What about strengths? What have you discovered in yourself that you didn’t know was there? Did you uncover some new powers, some new strength, some better understanding of what you’re capable of? Has it been a learning experience for you to Marco Calabi (49:05) Okay. Yes. Yes, after the writing of my books was a moment of reflection because in that moment I asked to myself, I’m able to write a book, so what can block me? And in this moment, in that moment, I was able to do other things. Maybe here write another book, like choosing a social media manager for my Facebook and Instagram and asking. to hospitals and associations to tell my stories, creating podcasts and so on because writing the book created a moment, a precise moment of going forward. And in that moment, I aware. of my powers and my skills to go on. It was… Bill Gasiamis (51:02) Yeah. Yeah. You wrote a book, you did podcasts, you helped your community by speaking. You did all these things that you haven’t done before the stroke. Marco Calabi (51:10) Yes. Yes, and for example, now I’m discussing with a company for a possible speech of myself to inspire other people. And I’m telling the truth. I’m very, very happy because I hope this… Bill Gasiamis (51:30) Yeah. Marco Calabi (51:41) will ⁓ create something beautiful because I’m available to tell my story, to sell, perhaps something helpful. My best friend. Bill Gasiamis (52:01) Yeah, you know what I like about what I like about strokes and bio-codes? Sorry, go ahead. Marco Calabi (52:08) My best friend said, you are wiser. I don’t know. don’t know. I don’t know. Yes, yes. Before, was very hard. I was very, because my father was very hard. And I learned. Bill Gasiamis (52:19) Wiser. Wiser than before. Maybe. Marco Calabi (52:37) to be very hard. after the stroke, understood that heartless is useless because you reach the hearts of people with softness, not with heartlessness. Heartlessness makes ⁓ you more hateful. and not more lovable. Bill Gasiamis (53:10) Yeah, understand. Yes, I agree. Very wise. That’s very wise. Very wise. ⁓ You know what I like about your telling your story in for another organization or to inspire people is a lot of the people in the audience will not have had a stroke or another health issue or anything like that. Marco Calabi (53:11) Go on, go on, sorry. Yes. Bill Gasiamis (53:37) And what I like about it is that now there’s several years have passed since your stroke. So you’re standing on a stage telling your story. And one day, if those people happen to have a stroke or a negative medical experience, they have a picture in their mind of once upon a time, I was sitting in a room and there was this gentleman who… told his story and he was telling us about how he overcame his challenges, how he ⁓ improved, how he got better. And maybe those people who are unwell now because something happened to them, like everybody in life, things go wrong. Maybe they could say, I remember that man and the story that he told me, and maybe I can take some action and do similar things and get better. Marco Calabi (54:27) Mm-hmm. Bill Gasiamis (54:32) like he did. Marco Calabi (54:32) Yes. I tell the truth. It is not easy. It’s not easy. The experience is made of steps. In steps, steps. In the beginning, I… Bill Gasiamis (54:50) steps. Marco Calabi (54:58) You want to prove yourself, you are able to do things. And these are very important to you. And then you change. Steps, you change. Because the situation is changing. And you cannot, cannot, get things before you experience all the steps. It is, in my opinion, impossible. You must live every step. The first steps are physical. And then your mind changes. But the first steps are physical and soft. and you can you must you must us us us let that eat you must us let you be because you are not a superman you are not a special man and every every person experience these steps little by little and so you must aware of this situation. Otherwise, try to go forward faster. And in my opinion, it is a very wrong way to go on. Bill Gasiamis (56:55) Very wise, my friend. Marco Calabi (56:56) Thank you, thank you! Thank you, thank you! Bill Gasiamis (57:03) Your friend was correct when he said that you are much more wise now. I agree with him. Marco Calabi (57:07) Okay, okay, okay. I will report you. Bill Gasiamis (57:15) Report back to him, let him know that I agree with him. Now, your book is available online, correct? We can get it on Amazon, everywhere. Marco Calabi (57:21) Yes. Okay. Because in Italy, ⁓ I found a publisher. In the world, I decided to publish myself the book because I wanted to spread my story. as full as possible, I would say. And so I think what is the best platform, in my opinion, it is in this moment, Amazon. Because it can provide a digital version, paper version. ⁓ Bill Gasiamis (58:07) Yeah. Marco Calabi (58:18) is only for US countries and so on. Instead, digital fashion is worldwide. And so, it is very powerful because I can reach every person in the world. Bill Gasiamis (58:44) Yes, hopefully. Marco Calabi (58:45) It was my idea. And I started and I make my book translated. I published it in Amazon. I created a digital paperback version and so on because I wanted to make it available. Very, very much. Bill Gasiamis (59:19) Yes, indeed. you have well done. I’m going to have a link to the Amazon ⁓ book. And also you will send me some links to ⁓ any other areas you would like us to send people if they’re interested to find out more information about it. I thank you for reaching out and joining me on the podcast. I very much appreciate it. It’s nice to meet you and to hear your story and all the best with your ongoing recovery. Marco Calabi (59:24) Okay. Okay. Thanks. Yes. Okay, and I say thank you, thank you, Bayard for your time, people, and thank you very much to tell my story and to give me the possibility to tell my story. Bill Gasiamis (1:00:08) Well, what a lovely conversation and what a journey and what wisdom to our listeners. If today’s episode resonated with you, please share it with someone who needs to hear it. Leave a comment and leave a review. Subscribe if you haven’t already. Marco’s book, Life Change to Hell and Back is available on Amazon. The link is in the description below. And remember, if you want to stay on top of the latest stroke research without the overwhelm, turnto.ai has you covered. just $2 a week use code bill for 10 % off. Link is in the description And until next time, keep going. The post Return to Work After Stroke – Marco Calabi’s Honest Recovery Story appeared first on Recovery After Stroke.

Learn more about Brodie's Research Database & AI Assistant

In this episode, Ben explores Herzberg's Motivator Hygiene Theory and explains how leaders can use it to better understand team motivation. This is an older theory, but recently it has been re-examined with further research studies which tend to confirm it is still quite a valid way to think about motivation. Hygiene factors such as salary, a safe workplace, policies and procedures create a baseline for motivation, but do not generate high engagement on their own. Motivators such as interesting work, recognition, appreciation, development opportunities and purpose drive higher levels of intrinsic motivation and discretionary effort. Ben explains the importance of ensuring hygiene factors are in place, while also focusing on individual motivators that managers can influence directly. He also discusses refreshed research that continues to support the two-factor structure in modern workplaces. Resources mentioned in this episode: Herzberg's Motivator Hygiene (Two-Factor) Theory Some refreshed research on the two-factor model: Paper 1, Paper 2, Paper 3. Work with Ben 1 on 1.

Rashes, redness, and flare-ups- if you struggle with Rosacea, you'll know exactly what we're talking about. Other symptoms of Rosacea are characterized by visible blood vessels, pus-filled pink spots, and swelling. While most people who have this condition are genetically susceptible to it, there are various elements that may also play a part. Factors such as being exposed to UV radiation or extreme temperatures are a few examples. To help you manage these symptoms, I'll be sharing 5 expert tips. Tune into this Five Min Friday to find out what they are!

Erin Lynes, Kim Palermo, Crystal Wing, and Denise Fenzi, all presenters from the upcoming one day conference on Building the Bond join me to talk about what goes into building a bond with a dog.

Chinese discourse places particular emphasis on the role of the US, evaluating both the strategic feasibility of deeper American involvement and the broader geopolitical consequences. Watch Sana Hashmi explain why China views India as as an emerging variable in the US - China AI equation, on this week's #EyeOnChina --------------------------------------------------------------------------------------------- To read Column: https://theprint.in/opinion/eye-on-china/how-china-sees-irans-post-khamenei-trajectory-it-depends-on-four-factors/2870248/

Send me a question or story!In this week's podcast episode, I get to interview Allison Inga, DVM, DACVD who practices at Animal Dermatology Clinic in Robbinsville, NJ. We take a practical, clinician-focused look at the latest guidelines from the International Society of for Companion Animal Infectious Diseases (ISCAID) on the use of topical therapy in managing bacterial skin infections.Topical therapy is no longer just an adjunct — it's a central component of antimicrobial stewardship in dermatology. We review how the ISCAID guidelines support cytology-driven diagnosis, when topical therapy can be used as sole treatment, and how it helps reduce systemic antibiotic use in cases of superficial pyoderma and Malassezia dermatitis. 00:00 – Intro01:25 – Dr. Inga 03:50 – Advantages of Topical Therapy in Pyoderma Cases05:40 – Evidence of Using Chlorhexidine Percentages08:22 – Factors to Consider In Chlorhexidine Cases09:30 – Other Topical Anti-Septics to Consider10:44 – Diluting Bleach 13:50 – Addressing Concerns Around Bleach15:00 – Topical Antibiotic Use17:26 – Efficacy of Topical Therapy21:20 – Simple Things That Yield Good Results23:10 – Concurrent Use26:10 – Outro

Sarah rewatches and Heather is never bored. THANK YOU to our Patrons! Please consider directly supporting us at Patreon for ad-free episodes, access to our Discord server, and all around good vibes as you help us keep the lights on.Support this show http://supporter.acast.com/hsgd. Hosted on Acast. See acast.com/privacy for more information.

In this panel discussion from the Inch 360 Conference, cybersecurity experts explore the intersection of compliance, insurance, and risk management. Moderated by Maria Braun (Baker Tilly), the panel features Casey Wheeler (Marsh McLennan Agency), Dan Brown (CISA), and Deb Wells (BECU).Key Topics Covered:The Compliance vs. Security MythWhy having SOC 2, ISO 27001, or PCI-DSS doesn't automatically mean you're secureHow to move beyond "check-the-box" compliance to holistic risk managementThe importance of building security in, not bolting it onCyber Insurance EssentialsTop 5 controls insurers look for: MFA, comprehensive backups, email filtering, security awareness training, and wire transfer verificationHow insurance underwriting works and what carriers assessWhy you should contact your carrier FIRST during an incidentCommon policy pitfalls: waiting periods, coverage triggers, and business interruption termsEffective Risk ManagementHow to run meaningful tabletop exercises (not just compliance theater)Why you need to include the right people: IT, legal, HR, facilities, and your insurance carrierThe importance of making cybersecurity a daily habit, not a one-time eventHow to quantify risks and prioritize using heat maps and business impactThird-Party RiskWhy outsourcing doesn't transfer all responsibilityThe growing importance of vendor risk managementHow downstream attacks can impact your operations We're thrilled to be sponsored by IXL. IXL's comprehensive teaching and learning platform for math, language arts, science, and social studies is accelerating achievement in 95 of the top 100 U.S. school districts. Loved by teachers and backed by independent research from Johns Hopkins University, IXL can help you do the following and more:Simplify and streamline technologySave teachers' timeReliably meet Tier 1 standardsImprove student performance on state assessments

In this episode of "What's the Risk" we take a look at the Fama French US Small Value Research Index. It is a research index from the Fama French model that tracks the performance of stocks with low price-to-book ratios.While over the long term, the value factor has shown outstanding performance, in recent years it has underperformed generally against large cap growth, but was stronger at least globally in 2025. Critics of various factors will point to such periods of underperformance as evidence that they no longer work, but this is often done during those periods of underperformance, and factors, such as value, have had many periods of underperformance against the wider market, but over the longer term performance has emerged. For investors who want to tilt their portfolio to target higher expected returns, this is a lesson in risk. Factors are not going to always perform as you wish,and they have historically required patience and discipline to capture. The index was created by academics Eugene Fama and Kenneth French, the Fama French US Value Research Index is not an investible index, but the research by Fama and French has, and continues to inform Dimensional Fund Advisors, where Fama and French are board members. Want to learn more about investing? Search for "Your Investment Philosophy" on Amazon, Australian link: https://www.amazon.com.au/Your-Investment-Philosophy-Protecting-Fraudsters-ebook/dp/B0BCPJ8BGC/ https://www.mfg.com.au Mancell Financial Group is an Authorised Representative No. 226266 and Credit Representative No. 403187 of FYG Planners Pty Ltd, AFSL/ACL No. 224543. ABN 29 009 541 253. Hosted on Acast. See acast.com/privacy for more information.

A screencast from Chapter 17 in CH 222 entitled “Factors Affecting Reaction Rates”

Cardon is joined by Adam and Madeline Packer for a candid conversation exploring how Adam used an Excel spreadsheet as part of his decision-making process when choosing his wife.The story launches with some classic Ward Radio banter and playful jokes, but quickly turns to Adam's unique approach to relationships. While taking an advanced Excel modeling class for his finance degree, Adam realized he could repurpose a weighted averages project—originally meant for evaluating job opportunities after college—to help him decide who to seriously pursue in his dating life. Factors he ranked included being strong in the gospel, desire for a temple marriage, family compatibility, and, openly, attractiveness (“hotness” getting a high weight on the spreadsheet!).

The Year of the Extraordinary - Part 9 March 1st 2026 - Sunday Morning

On today's episode, Andy answers your questions on what habits you need to leave behind to become a better version of yourself, how to overcome guilt around wanting to earn more money, and how to know if your business is truly scalable.

 Brad shares results from a large national research project examining somatic cell count (SCC) and mastitis risk in U.S. organic dairy herds, using more than 2 million DHI test-day records from 430 farms across 31 states. The discussion highlights how SCC is influenced by multiple factors, including cow age, stage of lactation, milk production, breed, season, region, and herd size. Older cows, early-lactation animals, and lower-producing cows were most likely to have elevated SCC, while heat stress—especially during summer months—and larger herd size significantly increased risk. Because organic systems cannot rely on antibiotics, Brad emphasizes prevention strategies such as improved fresh-cow management, heat abatement, careful monitoring of chronic cows, and strong milking hygiene as key tools for controlling mastitis and maintaining milk quality. Questions, comments, scathing rebuttals? -> themoosroom@umn.edu or call 612-624-3610 and leave us a message!Linkedin -> The Moos RoomTwitter -> @UMNmoosroom and @UMNFarmSafetyFacebook -> @UMNDairyYouTube -> UMN Beef and Dairy and UMN Farm Safety and HealthInstagram -> @UMNWCROCDairyExtension WebsiteAgriAmerica Podcast Directory 

There are many parts behind the spike in crude oil prices underneath headlines of the strike on Iran. From the pipelines to the international players beyond the Middle East, Kevin Green explains the many pieces behind the crude oil puzzle to watch in the days ahead. KG later explains how this big picture plays a role in gold and silver prices moving higher. ======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Mind Pump Fit Tip: How much of an impact do these 5 things really have on your health & fitness goals? (2:15) Cardio life for Sal. (26:30) Why you need a sleep routine, not a morning routine. (30:34) The importance of daily movement. (34:33) Pre and post Vuori style. (39:08) The coolest machines ever! (40:15) Sports performance. (43:58) Admiring LMNT's rise. (48:12) Steve Austin's important training advice for the youth, and the value of practicing the skill. (51:09) #Quah question #1 – When it comes to deadlifts, when should I use a traditional barbell and when should I use a trap bar? (57:51) #Quah question #2 – What are good non-meat protein options during Lent, as a Catholic, we abstain from meat on Fridays? Not a big fan of fish. (59:55) #Quah question #3 – If I don't get enough protein daily, how does that affect my gains? (1:02:36) #Quah question #4 – Why do I love MAPS 15 programs so much?! (1:03:52) Related Links/Products Mentioned Visit Vuori Clothing for an exclusive offer for Mind Pump listeners! ** No code to receive 20% off your first order. ** Get a free Sample Pack of LMNT's most popular drink mix flavors with any purchase! Find your favorite LMNT flavor, or share with a friend. As always, LMNT offers no-questions-asked refunds on all orders. Visit: DrinkLMNT.com/MindPump MAPS Great 8 Launch - (Retail $127, Code: LAUNCH for 50% off!) ** Launch bonus include: MAPS GREAT 8 Nutrition Guide. ** Visit: http://mapsgreat8.com/  Mind Pump Store Mind Pump #2763: Eat as Much as You Want, but Don't Get Fat (JUST follow these 2 rules) Sleep loss limits fat loss, study finds Mind Pump #2497: The Amazing & Weird Side Effects of Creatine Trajekt Sports Stop Working Out And Start Practicing - Mind Pump Media Visit Paleovalley for an exclusive offer for Mind Pump listeners! ** Discount is now automatically applied at checkout 15% off your first order! ** Mind Pump #2450: The Smartest Way to Use Protein to Burn Fat & Build Muscle Mind Pump #2572: Only 15 Minutes a Day to Build Muscle & Burn Fat Mind Pump Podcast – YouTube Mind Pump Free Resources People Mentioned Paul J. Fabritz (@pjfperformance) Instagram Joe DeFranco (@defrancosgym) Instagram  

Introducing Brain Bytes, a new micro-cast hosted by Kelly Tremblay, PhD, neuroscientist, World Health Organization advisor, NIH grant reviewer, advocate, and professor. Brain Bytes features "byte"-sized nuggets of knowledge aimed at making neuroscience accessible for the senior living world.  In each episode, which will air on the fourth Friday of each month, Dr. Tremblay will share research-backed information related to aging and brain health. This week, she explores the different types of dementia and examines what evidence-based researchtells us about it. While encouraging listeners to take practical steps to support healthy aging, Dr. Tremblay explains that a significant portion of dementia risk may be modifiable. Factors such as education, physical activity, cardiovascular health, hearing and vision care, and social connection all play a role in supporting brain health across the lifespan. The following links accompany today's episode: • https://www.nia.nih.gov/health/alzheimers-and-dementia • https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01296-0/abstract • https://www.thelancet.com/infographics-do/dementia-risk We are grateful to Parker Health for their sponsorship of this micro-cast.

Send a textJosh Blum, Chris Stewart and John Vance look at how disciplined size-up and tight language reveal true critical factors and shape an incident action plan that works. We share tools for integrating risk management into strategy, avoiding busy work, and matching tactics to real resources.• why critical factors drive the incident action plan• three core size‑up questions that focus decisions• standard terms for fire conditions and why they matter• 360 and interior reports as continuous size‑up• overlaying risk management on strategy in real time• aligning tactics with actual staffing and capability• stopping duplication, avoiding busy work, keeping crews safe• leadership that prevents bad outcomes and sets clear limitsJoin us live March 11, 2026 for the instructor webinar on the download center and Blue Card resources. Sign up via the show notes to watch live, ask questions, or get the on‑demand replay. Sign up here: https://streamyard.com/watch/28zvKcGuWhZQBuy “Timeless Tactical Truths from Alan Brunacini” at bshifter.com in our store for only $10!This episode was recorded on February 27, 2026.For Waldorf University Blue Card credit and discounts: https://www.waldorf.edu/blue-card/For free command and leadership support, check out bshifter.comSign up for the B Shifter Buckslip, our free weekly newsletter here: https://lp.constantcontactpages.com/su/fmgs92N/BuckslipShop B Shifter here: https://bshifter.myshopify.comAll of our links here: https://linktr.ee/BShifterThanks for listening - please subscribe and give us your support! 

Most of the questions I've been asked lately have been about my current hormone replacement regimen. So I have dedicated this episode to unpacking what I use transdermally, orally, and topically for hormone replacement therapy. As you might expect, my approach includes the basics, along with a few additional strategies. I also share a topical option for facial skin that Dr. Felice Gersh recently recommended. Stay tuned to find out what I do for hormone replacement therapy. IN THIS EPISODE, YOU WILL LEARN: What you need to optimize first, before even considering adding any additional items Why I might need to increase the dosage of my Dotti transdermal estrogen patch Why I consider estradiol the most potent estrogen our bodies make before menopause Factors that influenced my decision to prioritize estradiol therapy The role of testosterone, beyond libido Why I use progesterone The value of intra-vaginal products Why I use a compounded intra-vaginal product  What copper peptides, estriol, DMAE, and hyaluronic acid may do for aging skin Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow  Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Research Links Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial Hormone Replacement Therapy Effects of Ultra–Low-Dose Transdermal Estradiol on Cognition and Health-Related Quality of Life   Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data Treatment of skin aging with topical estrogens SCF-induced airway hyperreactivity is dependent on leukotriene production The role of dimethylaminoethanol in cosmetic dermatology The Missing lnc(RNA) between the pancreatic β-cell and diabetes

Advocates are scrambling to raise money for rent for the families that are still in hiding and losing income due to the Minnesota ICE surge. A coalition of unions in Minnesota is calling for a rent strike in solidarity with those families starting March 1. Others are asking Governor Tim Walz to enact an eviction moratorium and rent relief payments for people unable to work during the surge of federal agents in the state. Advocates said they have crowdsourced hundreds of thousands of dollars to support the people in hiding, but that it is not sustainable for the long term. Gov. Walz said he can't enact a statewide eviction moratorium without declaring a peacetime emergency. So far, he has been unwilling to make that move. Professor Larry Jacobs, the founder and director of the Center for the Study of Politics and Governance at the University of Minnesota, broke down the legal and political considerations facing the governor around an eviction moratorium.

In this episode we are talking about uncertainty and risk along with patient preferences for communication. Segment 1: The attitudes of individuals with or at risk of adult-onset genetic conditions on reproductive genetic testing: A systematic review Shanice Allen is a PhD student from the Sheffield Institute for Translational Neuroscience (SITraN) at the University of Sheffield. The aim of her research is exploring the attitudes and experiences of individuals with or at-risk of genetic MND on reproductive genetic testing, and explore how and if clinicians discuss these options with these individuals. This will help us identify any barriers to accessing reproductive services. LinkedIn: https://www.linkedin.com/in/shanice-allen-9a89661a5/   In this segment we discuss: - The attitudes toward reproductive genetic testing in adult-onset genetic conditions. - Experiential knowledge and perceived disease severity in shaping reproductive decision-making. - Ethical themes including guilt, eugenics, and concerns about pregnancy termination. - Findings supporting more tailored, longitudinal genetic counseling approaches.   Segment 2: Assessing patient communication preferences for reclassified variants of uncertain significance in a general genetics clinic Eden Brush, MS, CGC is a pediatric and inpatient genetic counselor in the Division of Clinical Genetics at Columbia University Irving Medical Center. She completed her graduate training at Columbia University as part of the class of 2024. She is passionate about rare disease advocacy, narrative medicine, and disability justice.   In this segment we discuss: - Patient communication preferences for reclassified variants of uncertain significance (VUS) and patient-driven practice insights - Factors that emphasize the utility of shared responsibility, the need for standardized recontact systems, and the importance of equity-focused implementation strategies. - How VUS reclassification type impacted patient-preferred disclosure methods.    Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors.   Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”.    For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others.    Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com.    DNA Dialogues' team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today's Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Stephanie Schofield.

Sky TV says even though it's had a strong first-half financial year result - the television market remains challenging. It's reported a $52 million net profit, turning around a $1.7 million loss last period. Its revenue rose eight percent, to about $414 million. Sky TV chief executive Sophie Moloney says revenue for traditional TV was softer than expected. "The TV side does seem to be suffering a bit more than others, so I do think it's incumbent on us to make sure that we're talking about that value and allowing our clients to see the benefits." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Dr. Bishal Gyawali and Dr. Tessa Cigler share the new, comprehensive, evidence-based update of the ASCO guideline on the use of hematopoietic colony-stimulating factors in patients with cancer. They discuss recommendations on primary prophylaxis, secondary prophylaxis, and treatment of febrile neutropenia along with stem cell mobilization, efficacy, safety, duration, dosing, and administration of CSFs – including biosimilars. They highlight where it is appropriate to use a CSF, and importantly, when not to use a CSF. They touch on the significance of individual patient considerations and cost implications, and future work to refine the risk factors for the development of complications of febrile neutropenia. Read the full guideline, "White Blood Cell Growth Factors: ASCO Guideline Update" at www.asco.org/supportive-care-guidelines TRANSCRIPT This guideline, clinical tools and resources are available at www.asco.org/supportive-care-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology,  https://ascopubs.org/doi/10.1200/JCO-25-02938     Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts. My name is Brittany Harvey, and today I'm interviewing Dr. Bishal Gyawali from Queen's University in Kingston, Ontario, Canada, and Dr. Tessa Cigler from Weill Cornell Medicine in New York, New York, co-chairs on "White Blood Cell Growth Factors: ASCO Guideline Update." Thank you for being here today, Dr. Gyawali and Dr. Cigler. Dr. Bishal Gyawali: Thank you very much for having me. It's a pleasure. Dr. Tessa Cigler: Hi there. Nice to be here as well. Brittany Harvey: Great. And then before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO Conflict of Interest Policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Cigler and Dr. Gyawali, who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So then I'd like to dive into the guideline that we're here today to talk about. So first, what prompted an update to this guideline on the use of hematopoietic colony-stimulating factors in patients with cancer, and what is the scope of this updated guideline? Dr. Bishal Gyawali: The last version of the guidelines from ASCO on this topic was back in 2015, so it has been more than a decade since ASCO had a guideline on the use of G-CSF in patients with cancer receiving treatment. So it was due for an update because there has been a lot more evidence based on not necessarily new drugs, but evidence for proper timing of these agents and the duration of these agents, as well as there have been a lot of new biosimilars, and there are questions about are these biosimilars equivalent or how do we choose among these different options. One is that content of the evidence that has evolved over time in the last decade, but also I think the last time we had these guidelines, the ASCO guidelines were not incorporated to have those evidence GRADE tables. So the quality of the ASCO guidelines itself has evolved over the years, so we wanted to have a new version of the guideline that includes not only the new evidence, but also contains those evidence GRADE tables that will help to quantify the benefits. And so I think it was high time, and even more than that, the newer ASCO guidelines for any guideline, they also include considerations of cost, access, equity, and all these factors that were not included in the previous version of the guideline. So I think it's only natural that with time the guideline should also evolve. Dr. Tessa Cigler: I agree completely, and just as a framework, as we all know, neutropenia and its complications, including febrile neutropenia and infections, are still an important toxicity of many myelosuppressive chemotherapies. And these neutropenic complications do require prompt evaluation and treatment and often hospitalization, and we know that hematopoietic colony-stimulating factors, which I'm going to refer to as growth factors, can reduce the duration and severity of neutropenia and the risk of febrile neutropenia, so it remains an important topic in the practice of clinical oncology. Brittany Harvey: Absolutely. It's an important topic for both clinicians and for patients who are receiving treatment for their cancer. And as you said, there was a substantial amount of literature to review here and updating everything to be in line with the GRADE evidence rating system, so there was a lot of work that you both put into this. So then next, I'd like to review the key recommendations of this guideline by clinical question. So first, what factors did the expert panel identify that should influence the decision to administer primary prophylaxis of febrile neutropenia with a CSF? Dr. Bishal Gyawali: Yeah, so I think that constitutes one of the most important recommendations in our guidelines about primary prophylaxis with G-CSF. And this is important because not only it's about when to use it, it's also about when not to use it, as in the ASCO "Choosing Wisely" campaign has also made some recommendations about this. So our guideline recommendations are also aligned with that. So first of all, we recommend that primary prophylaxis with G-CSF is recommended when the risk of febrile neutropenia because of the chemotherapy regimen is equal to or more than 20% unless an alternative chemotherapy regimen with comparable efficacy and safety that does not need G-CSF is available. And the quality of evidence to make this recommendation is high, so we give a strong strength of recommendation for this. Having said that, even for patients where the risk of febrile neutropenia is not necessarily 20%, it's a little lower, but because of other patient-related factors, the patient is at a higher risk of complications from febrile neutropenia, such as age, comorbidities, and other factors, in such case primary prophylaxis with G-CSF should be offered. And we also make a recommendation that if G-CSF is not affordable or available, then antibiotic prophylaxis can also be offered, but the evidence quality for this is low, and the strength of recommendation is very conditional. A couple of things to highlight here would be that, I think Dr. Cigler can attest to that, we ran into lots of problems about finding the data for the evidence base to say what are the patient-related factors that actually make them at a higher risk of febrile neutropenia, you know, like how did that 20% benchmark come about? Why 20%? Or when we say even if it's less than 20%, if based on other comorbidities, if the risk is higher, we tried to dig into that evidence. For example, we're talking about our "Box 1" in the guideline, what is the evidence for each item we have included under that "Box 1"? And we tried to do a lot of search to find the evidence for that, and some of them do have strong evidence, and that will tie into our future research ideas as well. And some of them actually don't have such solid evidence too, so that was one of the reasons why we ran into lots of problems about how do we quantify whether someone is at a high risk of febrile neutropenia and where that 20% benchmark comes from. Dr. Tessa Cigler: And definitely, because there's not very clear data, our guidelines definitely leave room for physician discretion in all these situations. Brittany Harvey: Absolutely. I find that in a lot of these guidelines the key point is that there's a lot of shared decision-making with patients after talking through what risk factors they may have and what is best for them in their individual clinical scenario. So then moving on to secondary prophylaxis, what factors did the expert panel identify that should influence the decision to administer secondary prophylaxis of febrile neutropenia with a CSF? Dr. Tessa Cigler: So for patients who've already experienced a neutropenic complication from a previous cycle of chemotherapy, the question is which patients should then receive prophylactic G-CSF for subsequent cycles of chemotherapy. And without a lot of evidence again to guide us, the panel really felt strongly that secondary prophylaxis should be used when a treatment delay or when a reduced dose of chemotherapy would be thought to compromise cure rates or survival outcomes. We do note that in many situations, certainly a dose reduction or a delay would be a very reasonable alternative or an additional strategy to G-CSF administration. Dr. Bishal Gyawali: Yeah, I think it's more like if there is going to be compromise in outcomes without using G-CSF, as in if we can't maintain the dose intensity and that's going to lead to inferior outcomes, then we should. But if we can reduce the dose intensity and treatment frequency and still have the same outcomes, then I guess in simple words, we're just trying to say use it when it's absolutely needed, or you can also look into other alternatives that might not need G-CSF but you could maintain the same outcomes. Brittany Harvey: Understood. It's helpful to review those options for clinicians and showing that there's not just one way to address potential neutropenic complications for later cycles of chemotherapy. So then following those recommendations for prophylaxis, what does the expert panel recommend regarding CSFs for the treatment of febrile neutropenia? Dr. Bishal Gyawali: This is an important question because this ties strongly with the "Choosing Wisely" campaign. In other words, primary and secondary prophylaxis we talked about when CSF should be used; here we make a sort of negative recommendation in that we say when CSF should not be used, because this is where we see most overuse or overtreatment with G-CSF. So first, we say that we should not be using a CSF routinely simply because a patient has neutropenia. If they are afebrile but they only have neutropenia, we recommend against using CSF just to boost neutrophil counts; that's not a meaningful metric. Then the second recommendation we make is CSF should not be routinely used as an adjunctive treatment with antibiotic therapy for patients with fever and neutropenia. So the first one was neutropenia, no fever, don't use it. The second one is okay, there is neutropenia and fever, but the treatment for that is use of antibiotic therapy, and so in such situations routinely we should not be using G-CSF just to boost the neutrophil count. And that is tied on to the third recommendation where if the patient has fever and neutropenia but is also at a very high risk for infection-related complications or who have other prognostic factors that we think will lead to poor outcomes for the patient, then in such situations, a CSF can be used as an adjunctive treatment. But we talk about the data in the manuscript, but the data show that the most that this will do is reduce the days of hospitalization by a couple of days. It actually does not have any data that it's going to improve the mortality rates. So as of now, we use the word "may be offered," it's not "should be offered," it's "may be offered" if there are other factors that we think will make the patient at the very poor risk of mortality outcomes, and the evidence quality here therefore is low and our strength of recommendation is conditional. And we also have a box that lists those items that we think might be associated with poor prognosis for the patients, but again the data for those, are they really hard evidence? No. And that is also tied with our future research recommendation that we should study more about these factors that might lead to these poor outcomes. Dr. Tessa Cigler: And again, allowing for discretion of the treating physician. Brittany Harvey: Absolutely. It's just as important to know when not to use CSFs routinely, and those risk factor boxes that you mentioned are available in the full manuscript along with the full list of recommendations, and our listeners can refer to that; a link will be in the show notes of the episode . Dr. Tessa Cigler: Just so you know, the panel, we really discussed those criteria a lot and agonized over them and gave you our best recommendations. Brittany Harvey: Definitely, and it sounds like there was varying degrees of evidence to support a lot of those risk factors, and so it's really important that the evidence supports those, but also there was expert consensus of the panel in reviewing each of those factors individually to come up with recommendations that can be applicable for all clinicians. Dr. Bishal Gyawali: If I may add, we're proud of our panel because I think our panel is quite inclusive of people representing different specialties within cancer care, as in we had radiation oncologist, we had infectious disease expert, pharmacists, and most importantly, we also had patient partners. Brittany Harvey: Absolutely. Having a multidisciplinary panel is really important for each and every guideline. So then, this is probably relevant now, but addressing a few more specific sections addressed in the guideline, what is the role of CSFs as adjuncts to progenitor cell transplantation? Dr. Tessa Sigler: Great question, and so, as solid tumor oncologists, Dr. Gyawali and I really leaned heavily on our hematology experts within the panel. The panel decided that a CSF should be used alone after chemotherapy or in combination with a CXCR4 inhibitor to mobilize peripheral blood progenitor cells. Clearly the choice of mobilization strategy depends on the type of cancer and the type of transplantation. The panel noted that a CSF should be routinely administered after autologous stem cell transplantation to reduce the risk of severe neutropenia, and that a CSF may be administered after allogeneic stem cell transplant to reduce the duration of severe neutropenia. Again, this last recommendation has not a lot of evidence to support it, and so we kind of tempered our language that it may be administered or can be considered based on clinical judgment of the physician and the clinical status of the patient. Brittany Harvey: And that really highlights the need for a multidisciplinary panel, because as you are solid tumor oncologists, you need the hematologists to make recommendations for all sorts of patients and make sure that these guidelines are comprehensive.   So then moving on to another smaller subset population, for patients receiving concomitant chemotherapy and radiation therapy, are CSFs recommended? Dr. Bishal Gyawali: I think there is very little evidence for patients who are receiving radiation therapy alone, so there is no evidence to suggest the use of CSF in patients with radiation therapy alone. The bigger question is in patients who are receiving both chemo and radiation together, chemoradiotherapy. In those patients, up until now, the classical recommendation has been to avoid G-CSF use. I think in our updated guidelines we discuss a couple newer trials that are trying to address this issue, but in the totality of evidence, we still stick with the same recommendation as before, which is CSFs are not recommended in patients receiving concomitant chemotherapy and radiation therapy, especially those involving the mediastinum because the biggest evidence of harm is for these patients. Dr. Tessa Cigler: I agree completely. Brittany Harvey: Definitely. It's important to recognize when that balance of benefits and harms leans more towards harms, and so that this should not be recommended for those patients. So there are several different CSFs that are recommended in the guideline, including biosimilars. So do the recommended CSFs differ in efficacy or safety? Dr. Tessa Cigler: So as supported by evidence, and the panel all agreed, that the various forms of CSFs, including the biosimilars, really have the same evidence for efficacy and for safety, and that the choice of agent really should depend on cost, availability, accessibility, patient convenience, and sometimes disease subtypes and treatment regimens. But, in essence, these can be used interchangeably without concern for efficacy or toxicity differences. Dr. Bishal Gyawali: I completely agree. I think in terms of efficacy outcomes, I don't think there is anything to choose between these agents. The choice between these agents would largely depend on different patient and treatment-related factors: cost, availability, affordability, feasibility. We even discuss things like where does the patient live, as in how frequently the patient can commit to the cancer center, and we also discussed things like even for the daily shots of filgrastim, patients can be taught and they can get it by themselves at home. So we discussed all these factors, but in a nutshell, the choice within these agents primarily depends not on efficacy factors, but simply based on all these other factors that are equally important but which can lead to informed decision-making about what is best for a given patient. But we mention it explicitly that the biosimilars, there is nothing to choose between them, especially the biosimilars; it's about price competition and what you can get at an affordable rate. Brittany Harvey: Understood. It's great to have many different options for patients so that there's something that can work for them based off access, cost, and all these factors that you listed. As you mentioned, it may be easier for some patients to get their treatment at home rather than in clinic, and so having different options and reviewing those with patients is very important. Dr. Bishal Gyawali: As we are having this conversation, I'm thinking that we might be a very unique guideline in that I don't think in many other settings you have this many options that you are asking about, you know, choices between equally good options and making decisions based on cost. I don't think there are any other areas in oncology where we have the privilege of making these decisions based on cost and convenience and all these factors, as well as we might be one of those guidelines where we have, as discussed before, so many recommendations about when not to do things and trying to promote judicial use of treatments. Dr. Tessa Cigler: As you might imagine, our panel discussions were very lively. Dr. Bishal Gyawali: Yes. But Dr. Cigler, do you recall any other guideline where there is so much discussion about when not to use things and how we have so many biosimilar options and we can choose the one that's most appropriate? I don't recall any other. Dr. Tessa Cigler: I agree with you. Brittany Harvey: It's certainly a unique guideline in that regard. So we'll move into the last clinical question that the expert panel addressed. But what does the expert panel recommend for the initiation, duration, dosing, and administration of CSFs? Dr. Bishal Gyawali: Yeah, I think there has been some new data in this regard that were not available in the previous guideline. For example, we have new trials testing a shorter duration of filgrastim injections compared to the standard of care. So we have some data, we call this 'de-escalation of treatment'. So we have more data supporting de-escalation of treatment. We have some data for lower dose of pegfilgrastim, we have data for lower duration of filgrastim, we have also some new data about timing of treatment, as in there has been some newer data presented about the relationship of timing of the drug and the frequency of adverse events from G-CSF such as bone pain. There is also the question about, for patients who don't live near the cancer center, can they get their pegfilgrastim shot on the day of chemo while they are in the cancer center? So all these questions that are very pragmatic and important questions, but were not answered before, we're glad that we had more evidence to talk about all these factors and give a more solid recommendation to our users of the guideline. Brittany Harvey: Definitely. And listeners can review the full list of dosing and administration recommendations in Table 2 in the guideline, and that will be linked in the show notes of the episode. So then I really want to thank you both for reviewing all of these recommendations. There's certainly a large amount of clinical questions and recommendations that you went through. I'd like to next ask, in your view, what is the importance of this updated guideline and how will it impact both clinicians and patients? Dr. Bishal Gyawali: I think the importance of this updated guideline is that, as mentioned before, we talk about newer data that have come up with regards to not just the most important two questions as in when to use it as primary prophylaxis and when to use it as secondary prophylaxis and when to use it as treatment, but also with regards to the duration and timing and dosing and multiple options and how these all factors as well as patient-related factors should be combined to make an informed decision, the most appropriate decision for the patient. And as mentioned before, we have the GRADE tables that were not in the previous version of this guideline. So I think even those users that are familiar with the 2015 guideline, I think they will find very novel content in this new updated guideline, and they will find it useful for their practice. I would encourage the readers to not only read the headlines of the box recommendations, but also read the full text of these guidelines because we have worked really hard to incorporate the latest evidence and also interpret them contextually. The discussion regarding de-escalation, patient considerations, cost implications; usually, people just skip these portions when they read a guideline. But I think these are also one of the most important paragraphs in our guideline, so they have been written with very careful thought, and I think reading the whole guideline is very much worth your time. Dr. Tessa Cigler: As you can imagine, I agree completely, having just spent several months thinking about these guidelines and all their nuances. Brittany Harvey: Certainly, this guideline is definitely a very comprehensive update, and that nuance in the manuscript is really important for clinicians to understand and read through and understand when it's appropriate to make certain decisions. So then to wrap us up, I'd like to ask, what are the outstanding questions and active research areas regarding the use of white blood cell growth factors in patients with cancer? Dr. Tessa Cigler: As you all know from clinical practice and that we've said several times already in this podcast is that the risk factors for the development of complications of febrile neutropenia are still not clearly worked out. And one of the things that is, I think, really needed in clinical practice is the development of predictive algorithms or biomarkers to really allow us to understand who might be more at risk and to allow for the clinician to be able to tailor the use of G-CSF as needed. Brittany Harvey: Yes, and so we'll look forward to future updates in this space to inform new recommendations and an updated guideline in the future. So I want to thank you both so much for your work to develop this comprehensive guideline. It was certainly a lot of effort, and thank you for your time today, Dr. Gyawali and Dr. Cigler. Dr. Tessa Cigler: Oh, my pleasure. It's nice to be here and to speak with you all. Dr. Bishal Gyawali: Yeah, it was great to speak with both of you but also through you to the audience, and we had a great time. Thank you. Brittany Harvey: And then finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/supportive-care-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

On this episode of the Chasing Clarity Health & Fitness Podcast, Jeff Hoehn and I kick off a new monthly collaboration series where we break down listener questions and dive into the strategies that actually move the needle for physique progress, fat loss, recovery & long-term health.We start with personal updates, then move into one of the most important conversations in physique coaching — why most people try to diet before their body and lifestyle are ready.THIS EPISODE COVERS:JEFF'S “HOLDING PHASE” APPROACH TO TRAINING & HEALTHBRANDON'S 24–28 WEEK BUILDING PHASE, TRAINING SPLIT & CALORIE INTAKEWHY A PRIMER PHASE IS CRITICAL BEFORE FAT LOSSPHYSIOLOGICAL FACTORS THAT DETERMINE FAT LOSS READINESSMETABOLIC ADAPTATION & DIETING HISTORYHUNGER & APPETITE REGULATION BEFORE DIETINGTHE NEED FOR TIME OUT OF A DEFICITBUILDING MUSCLE BEFORE GETTING LEANMANAGING A TIGHT SCHEDULE WHILE TRAININGCIRCADIAN RHYTHM, MEAL TIMING & EVENING TRAININGADVICE FOR TAKING BETTER CHECK-IN PHOTOSHOW TO IMPROVE RECOVERY & REDUCE SORENESSPERI-WORKOUT NUTRITION & PERFORMANCE RECOVERYWHAT TO LOOK FOR IN A HIGH-QUALITY SUPPLEMENT COMPANYTHIRD-PARTY TESTING, LABEL TRANSPARENCY & GMP STANDARDSIf you're someone who wants to approach fat loss, physique development & performance with a health-centric, evidence-based strategy, this series is for you.WHERE TO CONNECT WITH ME:Follow Brandon on IG: https://www.instagram.com/brandondacruz_/Email: Bdacruzfitness@gmail.comFor Info on Brandon's Coaching Services: https://form.jotform.com/bdacruzfitness/coachinginquiryBrandon's Website: https://www.brandondacruzfit.comMy Reading Recommendations: THE MUSCLE & STRENGTH PYRAMIDS https://getdpd.com/cart/hoplink/25469?referrer=1l54og96lf1ccw

Here I offer a guided meditation through the 16 steps of mindfulness of breathing with the seven factors of awakening. A very thorough journey through the body, mind, and heart, with tones of joy and contentment, with insight into impermanence.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Risk Score Development to Predict Postpartum Cardiovascular Disease Incorporating Pregnancy and Nonpregnancy Factors: A Canada-Wide Study.

Let's talk about the phrase you see alllll over social media: calories in, calories out.According to the internet, it's the *only* thing that matters. Just “eat less, move more,” and BOOM - problem solved.But…there's a WHOLE lot of “fine print” that gets skipped over here. If you've ever felt like CICO “doesn't work” for you, this episode is going to clear it up!Yes, calories in, calories out IS the foundation, but there is sooo much that influences those calories. Factors like hormones, stress, sleep, perimenopause, thyroid issues, insulin resistance, medications, and more ALL play a part! Calories in, calories out is absolutely real - it's the basis of every fat loss strategy out there. However, it's NEVER going to be *just* your calorie intake that will lead you to reach your fitness goals.Make sure you're using a smarter plan, and actually follow it - not your mood. That alone will help you greatly, friend!Episode recap:Why calories in, calories out is the foundation for fat lossWhy CICO is real (but it's not the whole story)3 reasons why the scale probably isn't movingWhy undereating doesn't help w/fat loss (it actually makes it harder)4 non-negotiables to “lock in” before you change everything elseHow to simplify your plan + honestly look at your outputMaking ONE change at a time + giving it time to workWhy CICO can work for you, but you need a smarter approach Links/Resources:Ep. 229 | What Training Volume & Intensity Actually MeanGrab your FREE Body Recomp Meal Prep and get the UFYF NewsletterListen to the Girls with Opinions PodcastJoin FIT CLUB, my monthly membership with workouts you can do at home or the gymPRIVATE COACHING is my 1:1 program (choose 3 or 6 month option)Connect with me on Instagram @kristycastillofit and @unfuckyourfitnesspodcast so we can keep this conversation going-be sure to tag me in your posts and stories!Join my FREE Facebook group, Unf*ck Your FitnessClick HERE for my favorite fitness & life things!Send me a text with episode ideas or just to say hi! Support the show

The Year of the Extraordinary - Part 8 February 22nd 2026 - Sunday Morning

Andrew Humberman BioSnap a weekly updated Biography.Andrew Huberman, the Stanford neuroscientist and host of the worlds top health podcast, dropped his latest Huberman Lab episode on February 23, just yesterday, diving deep into restoring youthfulness and vitality to the aging brain and body with guest Dr. Tony Wyss-Coray, a Stanford neurology professor pioneering blood biomarkers for organ health and disease risk, as detailed on the official Huberman Lab site. They unpacked young blood factors, rejuvenation via exercise and fasting, NAD levels, NMN supplements, and how sunlight plus deliberate deep breathing combat accelerated aging—timely stuff with massive long-term implications for anti-aging science that could redefine longevity protocols. No public appearances or business moves popped up in the last few days, but his podcast dominance holds steady, regularly topping charts on platforms like iHeart and Amazon Music. Social buzz simmers too: Food Ingredients First spotlighted Hubermans frequent plugs for hydrogen water as a potential 2026 breakout functional beverage, while STAT News on February 20 quoted him praising nicotine for sharpening the mind, fueling biohacker chatter among influencers like Joe Rogan. Fast Life Hacks updated its February 2026 rundown of his supplement stack—Tongkat Ali, Fadogia Agrestis, omega-3s, and sleep aids like magnesium threonate—based on his recent Rhonda Patrick chat, hinting at tweaks to his testosterone-boosting routine that keep fans dissecting his protocols. No verified headlines scream drama, but this episode rollout cements Hubermans grip on neuroscience gossip, with whispers of premium membership perks like AMA access drawing over a million email subs. All quiet on personal fronts—no unconfirmed rumors or scandals, just pure science fueling the wellness whirlwind.Get the best deals https://amzn.to/3ODvOtaThis content was created in partnership and with the help of Artificial Intelligence AI

Dr. Tony Wyss-Coray, PhD, is a professor of neurology at Stanford School of Medicine who is discovering factors present in young blood and in exercised blood that can improve brain, heart and other organ health. We discuss how different organs age at different rates and how to accurately measure biological aging. We also discuss the specific proteins found in blood when we are young and that are increased by things such as exercise, sunlight exposure, short-term fasting, specific foods and social connection that can significantly increase vitality, restore youthful functioning of the brain and body and potentially increase lifespan. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman David: https://davidprotein.com/huberman LMNT: https://drinklmnt.com/huberman ROKA: https://roka.com/huberman Function: https://functionhealth.com/huberman Timestamps (00:00:00) Tony Wyss-Coray (00:03:00) Young vs Old Animals, Age-Related Disease (00:06:35) Blood Biomarkers, Young vs Old Humans, Alzheimer's Disease (00:12:50) Sponsors: David & LMNT (00:15:28) 'Young Blood' Factors, Rejuvenation, Stem Cells (00:20:15) Blood Banking; Dracula (00:23:10) Rates of Aging in Organs, Age Gap & Disease Risk; Risk Profiles & Therapies (00:33:02) NAD Levels & Aging, NMN Supplements (00:36:44) Vitality vs Longevity; Periods of Accelerated Aging (00:43:17) Sponsors: AG1 & Roka (00:45:22) Sunlight; Youthful Blood Factors, Exercise & Brain Function, Fasting (00:51:25) Exercise, Injury & Inflammation (00:56:18) Pro-health Factors, Klotho, GDF11, Stem Cell Injection Risk (01:02:35) Platelet-Rich Plasma (PRP); Exosomes (01:05:43) Smoking, EMFs, Plastics, Long-Term Accumulation, Fresh Foods, Organic Food (01:11:28) Sponsor: Function (01:13:16) Intermittent Fasting, Long-Term Fasting, Snacking (01:19:07) Sleep; Cerebrospinal Fluid (CSF) Factors & Cognitive Function (01:24:44) Exercise Type & Longevity; Exercise Enjoyment (01:32:02) Lifestyle Factors & Alzheimer's Risk; Cognitive Exercise; Chocolate (01:37:05) Alcohol & Social Connection; US vs European Food Culture (01:40:50) Deliberate Deep Breathing; Wearables, Sunlight & Artificial Light (01:49:13) Future Projects (01:56:40) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

Send a Text Message. Please include your name and email so we can answer you! Please note, this does not subscribe you to our email list, it's just to answer if you have a questions for us. Back on your GLP-1 medication… but confused why it isn't working this time?Lots of people stop these medications for valid reasons. Cost, side effects, pregnancy plans, or simply because things were going well and it felt like the right time to try managing without them. But when weight creeps back on and you restart, it can feel really frustrating when results don't look the same.In this episode, I talk through why that happens. Factors like muscle loss, metabolism changes, weight regain patterns, and higher stress levels can all change how your body responds the second time around. If you're feeling stuck or wondering what changed, this episode will help you make sense of what's going on and figure out your next steps without beating yourself up.ReferencesGet the free podcast roadmap for The Obesity GuideJane Pilger: The GatheringA monthly guided experience to help you slow down and learn how to trust yourself.Slowing Down to the Speed of Joy by Matthew Kelly Back to Basics Mini Podcast Series 2025Ep. 100: HydrationEp. 101: ProteinEp. 102: FiberAudio Stamps00:30 - Why GLP-1 medications may stop working when you restart them after taking a break.01:20 - Book recommendation: "Slowing Down to the Speed of Joy" and how constant busyness prevents you from addressing behaviors that aren't serving you.04:04 - The common pattern: success, stopping medication, weight regain, then struggling when restarting.06:25 - Why it's harder the second time: muscle loss, weight cycling, and mismanaged expectations all impact your results.09:00 - The importance of updated lab work and comprehensive metabolic assessment before restarting.10:35 - How chronic stress and high cortisol prevent weight loss, even on medication.14:35 - The real work: learning nervous system regulation instead of constantly fighting cravings and urges.All of the information on this podcast is for general informational purposes only. Please talk to your physician and medical team about what is right for you. No medical advice is being on this podcast. If you live in Indiana or Illinois and want to work with doctor Matthea Rentea, you can find out more on www.RenteaClinic.com Not Sure Where to Start With the Podcast? I've Got You.Get my free Podcast Roadmap—a simple guide to help you find the episodes that matter most to your journey. Whether you're on GLP-1s, navigating plateaus, or just starting out, there's something here for you.Support the show

Cattle Market Movement Contributors Importance of Phosphorus in Mineral Faces in Agriculture: Anita Clubine   00:01:05 – Cattle Market Movement Contributors: Beginning the show is Derrell Peel, Oklahoma State University livestock economist, with his cattle market outlook where he discusses the Cattle on Feed report and what factors have been contributing to market movement.   00:12:05 – Importance of Phosphorus in Mineral: K-State Extension beef cattle specialist, Justin Waggoner, continues today's show as he reminds cattle producers about the importance of mineral supplementation, especially phosphorus.  ASI Newsletter - Feedlot Facts   00:23:05 – Faces in Agriculture: Anita Clubine: Anita Clubine from Montgomery County ends today's show with a segment of Faces in Agriculture where she explains how her operation has evolved and expanded.      Send comments, questions or requests for copies of past programs to ksrenews@ksu.edu.   Agriculture Today is a daily program featuring Kansas State University agricultural specialists and other experts examining ag issues facing Kansas and the nation. It is hosted by Shelby Varner and distributed to radio stations throughout Kansas and as a daily podcast.   K‑State Extension is a short name for the Kansas State University Cooperative Extension Service, a program designed to generate and distribute useful knowledge for the well‑being of Kansans. Supported by county, state, federal and private funds, the program has county Extension offices statewide. Its headquarters is on the K‑State campus in Manhattan. For more information, visit Extension.ksu.edu. K-State Extension is an equal opportunity provider and employer.

We have a fun episode of The Dunker Spot coming your way! Nekias Duncan and Steve Jones discuss Cade Cunningham's awesome performance against the Knicks (42 points, 8 rebounds, 13 assists, 1 steal, 2 blocks), as well as his status in the league. Is he gunning for MVP? Is he the best player in the league right now? From there, the guys open up the Dunker Spot mailbag. They talk through anti-tanking proposals sent in by the Dunkers, explore the Dallas Wings' ability to compete immediately with Paige Bueckers, share their favorite-looking jumpers in the NBA and much more! Finally, the guys preview the upcoming slate of Unrivaled games -- Angel Reese is back, y'all! -- with the playoffs rapidly approaching. If you ever have NBA or WNBA questions, email us at dunkerspot@yahoo.com. 2:27 Cade Cunningham is awesome 11:21 Anti-tanking rules are coming (plus proposals from the mailbag) 26:33 Appreciating Alanna Smith's defense 29:51 Deni Avdija's right-hand drives 33:25 Can Paige Bueckers and the Wings contend for a title next season? 37:05 Kawhi Leonard or Chelsea Gray shot-making? 39:17 Most aesthetically pleasing jump shots in the NBA 41:46 Why players are more willing to compete in the 3PT contest vs Dunk contest 44:36 Factors impacting the "Face of the League" selection 47:54 Ayo Dosunmu's 6th Man of the Year chances 50:22 What should Kings fans look forward to for the rest of the season? 53:12 The schematic balancing act of implementing new players + Nekias' basketball background 58:37 Who's the most rudderless team in the NBA? 01:00:10 Unrivaled preview Subscribe to the The Dunker Spot on your favorite podcast app:

We have a fun episode of The Dunker Spot coming your way! Nekias Duncan and Steve Jones discuss Cade Cunningham's awesome performance against the Knicks (42 points, 8 rebounds, 13 assists, 1 steal, 2 blocks), as well as his status in the league. Is he gunning for MVP? Is he the best player in the league right now? From there, the guys open up the Dunker Spot mailbag. They talk through anti-tanking proposals sent in by the Dunkers, explore the Dallas Wings' ability to compete immediately with Paige Bueckers, share their favorite-looking jumpers in the NBA and much more! Finally, the guys preview the upcoming slate of Unrivaled games -- Angel Reese is back, y'all! -- with the playoffs rapidly approaching. If you ever have NBA or WNBA questions, email us at dunkerspot@yahoo.com. 2:27 Cade Cunningham is awesome 11:21 Anti-tanking rules are coming (plus proposals from the mailbag) 26:33 Appreciating Alanna Smith's defense 29:51 Deni Avdija's right-hand drives 33:25 Can Paige Bueckers and the Wings contend for a title next season? 37:05 Kawhi Leonard or Chelsea Gray shot-making? 39:17 Most aesthetically pleasing jump shots in the NBA 41:46 Why players are more willing to compete in the 3PT contest vs Dunk contest 44:36 Factors impacting the "Face of the League" selection 47:54 Ayo Dosunmu's 6th Man of the Year chances 50:22 What should Kings fans look forward to for the rest of the season? 53:12 The schematic balancing act of implementing new players + Nekias' basketball background 58:37 Who's the most rudderless team in the NBA? 01:00:10 Unrivaled preview

          According to recent surveys, the number of people who say they are experiencing burnout is on the rise. Dr. Zarya Rubin practices functional medicine in Portland who specializes in identifying and relieving burnout. She started a podcast last year that she both produces and hosts called “Outsmart Burnout.” She says burnout can manifest as physical and mental exhaustion, brain fog, an increase in anxiety and a decrease in productivity. The factors that contribute to this phenomenon can include almost every aspect of life from work and family dynamics to national politics. We sit down with Rubin to hear more, including her recommendations for getting relief - and take your calls. Our call-in number is 888-665-5865.

Wild turkey biologist Reina Tyl joins us to unpack her comprehensive study assessing population growth of Easterns in South Dakota.    Resources: Lashley, M. A., et al. (2025). Decreased female survival may explain wild turkey decline. bioRxiv, 2025-05. Tyl, R. M. (2019). Factors Influencing Survival, Productivity, and Population Growth of Eastern Wild Turkeys in Northeastern South Dakota. West Virginia University. Tyl, R. M., Rota, C. T., & Lehman, C. P. (2025). Factors influencing eastern wild turkey population growth in northeastern South Dakota. Wildlife Society Bulletin, 49, e1636. Tyl, R.M., Rota, C.T. and Lehman, C.P., 2020. Factors influencing productivity of eastern wild turkeys in northeastern South Dakota. Ecology and Evolution, 10(16), pp.8838-8854. Tyl, R.M., Rota, C.T. and Lehman, C.P., 2023. Factors influencing survival of female eastern wild turkeys in northeastern South Dakota. Wildlife Society Bulletin, 47(2), p.e1429.   Our lab is primarily funded by donations. If you would like to help support our work, please donate here: http://UFgive.to/UFGameLab   Don't miss out on a chance to win a custom Benelli Super Black Eagle 3! This 28-gauge shotgun features a 28' barrel, 3" chamber, and is exclusively dipped in Mossy Oak Full Foliage not available to the public. Enter the online raffle below for a shot at owning this one-of-a-kind gun! This is literally a one-of-one collectable item. https://e.givesmart.com/events/Nqy/   We've launched our second online wild turkey course! Enroll in  Wild Turkey Manager: Biology, History & Habitat to learn about the principal biology, mating, behavior, food selection, human dimensions, hunter interactions, and historical context of wild turkeys. This course is accredited by the Society of American Foresters as a Category 2 course worth 7 Continuing Forestry Education credits. Participants can also earn up to 5 CEUs in Category I of The Wildlife Society's Certified Wildlife Biologist Program. Enroll now: https://tinyurl.com/WildTurkeyManagerBio   Be sure to check out our first comprehensive online wild turkey course featuring experts across multiple institutions that specialize in habitat management and population management for wild turkeys. Earn up to 20.5 CFE hours! Enroll Now!    Dr. Marcus Lashley @DrDisturbance, Publications Dr. Will Gulsby @dr_will_gulsby, Publications Turkeys for Tomorrow @turkeysfortomorrow  UF Game Lab @ufgamelab, YouTube   Want to help wild turkey conservation? Please take our quick survey to take part in our research!   Do you have a topic you'd like us to cover? Leave us a review or send us an email at wildturkeyscience@gmail.com!   Watch these podcasts on YouTube   Please help us by taking our (quick) listener survey - Thank you!    Check out the DrDisturbance YouTube channel! DrDisturbance YouTube   Want to help support the podcast? Our friends at Grounded Brand have an option to donate directly to Wild Turkey Science at checkout. Thank you in advance for your support!   Leave a podcast rating for a chance to win free gear!   This podcast is made possible by Turkeys for Tomorrow, a grassroots organization dedicated to the wild turkey. To learn more about TFT, go to turkeysfortomorrow.org.    Music by Artlist.io Produced & edited by Charlotte Nowak

Ajahn Dhammasiha talks about the importance of 'Beautiful, Admirable Friendship' (Kalyānamittatā) for our Dhamma progress. "Having good spiritual friends is 100% of the holy life" (The Buddha, Saṃyutta Nikāya/Connected Discourses 45.2)Ajahn points out the connection with the 4 Factors of Stream Entry (Sotāpattiyangāni):Association with Good Persons (Sappurisa-saṃseva) Hearing the True Dhamma (Saddhamma-savanaṃ)Wise Attention (Yoniso Manasikāra) Practising Dhamma in Line with Dhamma (Dhammānudhamma-patipatti)Number one is personal contact with someone who has realized the Dhamma. Personal association with an Arahant or Streamenterer, even if only for a short time, is the first of four conditions to realize the Dhamma oneself. Ajahn Dhammasīha encourages us not to completely substitute that personal association with youtube, reading and listening to recordings. Without the personal contact, we may miss out on a crucial factor for gaining the vision of Dhamma ourselves.Dhammagiri Forest Hermitage:⁠⁠⁠⁠https://www.dhammagiri.net/news⁠⁠⁠⁠Our email Newsletter:⁠⁠⁠⁠https://www.dhammagiri.net/newsletter⁠⁠⁠⁠Latest Photos⁠⁠⁠⁠https://latest-pics.dhammagiri.net⁠⁠⁠⁠Our Youtube Channel:⁠⁠⁠⁠https://www.youtube.com/⁠⁠⁠⁠@dhammatalksatdhammagiri8724#buddhism #friendship #goodfriends #buddhistwisdom #dhammatalk #dhamma #streamentry #sotapatti

Ben Criddle talks BYU sports every weekday from 2 to 6 pm.Today's Co-Hosts: Ben Criddle (@criddlebenjamin)Subscribe to the Cougar Sports with Ben Criddle podcast:Apple Podcasts: https://itunes.apple.com/us/podcast/cougar-sports-with-ben-criddle/id99676

For families of medically complex kids, where you live can determine what services your child gets, whether you can be paid to care for them, how long you sit on a waitlist, and whether the world around you is even built for a kid like yours.In this episode, Madeline and Alyssa dig into one of the most loaded and personal questions in this life: have you ever considered moving for better support for your child? We cover why so many of us feel that pull, what can make some places better or worse for our specific kids, and the brutal catch-22 of needing more financial support but not being able to afford to move somewhere that offers it. We also get into the Medicaid waiver maze, the politics and safety fears driving families out of certain areas, and the complicated grief on both sides — whether you want to move and can't, or moved and left everything you'd built behind.There's no single right answer, and no one place to point you toward. But if you've ever looked around and wondered whether somewhere else could be better, this episode is for you.And our FUEL The Rare Life fundraiser is live! Help us fund the podcast for another year by sharing our fundraiser with your loved ones and community so we can keep supporting you! Learn more here.Links:Share our FUEL The Rare Life fundraiser!Learn about Medicaid and waiver programs in your state at Kid's Waivers.Listen to Ep 171: Financial Strain.Listen to Ep 135: Career Impact.Listen to Ep 139: In-Home Nursing.Follow us on Instagram @the_rare_life!Join The Rare Life newsletter and never miss an update!Fill out our contact form to join upcoming discussion groups!Donate to the podcast or Contact me about sponsoring an episode. 

Panos sits down with Dr Will Magness — veterinarian and founder of 5 Hounds dog food, to unpack some of the biggest (and often most misunderstood) topics affecting dogs today.   The conversation explores the three major factors influencing dog health, why Dr Will started 5 Hounds, and the common issues seen in kibble-only diets. It also dives into proper feeding, the link between food and allergies, and the ongoing discussion around early desexing, including ideal timing and possible alternatives.   They examine whether dogs are being over-vaccinated, why yearly vaccinations are still commonly recommended, and what a titre test actually is and when it makes sense.   This is a balanced, practical conversation, not fear-based, not dogmatic — just honest discussion about diet, development, and long-term health.   For anyone serious about raising a healthy, resilient dog, this episode will get them thinking. Find Dr. Will at https://5hounds.com.au/ Find us online >> Panos @ www.npdogtraining.com >> Luke @ www.instagram.com/itslukebadman >> www.facebook.com/lifewithyourdogpodcast >> www.instagram.com/lifewithyourdogpodcast >> www.lifewithyourdogpodcast.com  

In this episode, Carina discusses the implications of AI coaching in the realm of running. While acknowledging the benefits of AI, she emphasizes its limitations, particularly in providing personalized coaching that accounts for human emotions and experiences. The conversation explores the importance of human interaction, accountability, and the risks associated with relying solely on AI for training plans. Ultimately, Carina advocates for the irreplaceable value of human coaches in fostering motivation and understanding in runners.TakeawaysAI coaching has limitations that can be dangerous.Human interaction is crucial in coaching.AI cannot understand the emotional aspects of training.Accountability from a coach motivates runners.AI can provide plans but lacks personalization.The human element in coaching enhances performance.AI can lead to injury if not monitored properly.Runners need emotional support during training.AI can be a tool, but not a replacement for coaches.Investing in a coach can lead to better results.

One of the biggest challenges I hear from business owners ready to scale their reach is disappointment in how to make collaborations produce results. What could be growth fuel for their business has actually become a time and energy drain. Frustrated, they give up instead of optimizing their strategic partnership strategy. So why do collaborations work so easily for some expert-preneurs, but become a high cost for others?  In episode 478 of Amplify Your Success podcast, I talk about the four discernment factors every leader needs to consider before saying yes to a collaboration. These are the filters that protect your time, your energy, your reputation, and your momentum as your visibility and opportunities increase. I share why misaligned collaborations create hidden costs, how discernment becomes more important than enthusiasm at higher levels, and what it actually looks like to build collaboration currency you can access on demand. This conversation is not about avoiding collaboration. It's about choosing aligned collaborations intentionally, so it compounds your authority instead of fragmenting it. If you've ever said yes to something that looked aligned but didn't feel aligned once you were inside it, this episode will help you understand why and how to choose differently moving forward.   Key Takeaways:  [00:00] Why collaboration becomes more complex, not simpler, as your visibility grows. [02:48] The hidden energetic, emotional, and strategic costs of misaligned collaborations. [05:31] Why enthusiasm is not a reliable decision filter at higher levels of leadership. [07:44] The four discernment factors that protect your time, energy, and authority. [10:22] How collaboration currency is built through trust, proximity, and contribution. [13:09] The difference between collaboration that compounds and collaboration that drains. [15:46] Why saying no strategically creates more long-term opportunity. [18:27] How aligned collaborations accelerate visibility without forcing momentum.   Resources Mentioned in This Episode: The Collaborative Currency System is a 5 step strategy to unlock aligned strategic partners and activate a stream of ideal clients and growth opportunities. Get started at  - https://melaniebenson.com/collaborate The Rising Tide Collective is an online community where experts and leaders come together to co-create visibility opportunities and aligned collaborations that lift everyone up. Each month you can participate in our signature mini-minds, a curated connection space, showcase your business, and gain access to tools to build powerful, profitable partnerships. If you're ready to lead at your next level, apply for membership at MelanieBenson.com/Collective.   

Date: February 13, 2026 Reference: Lang et al. Factors associated with emergency department length of stay in Alberta: a study of patient-, visit-, and facility-level factors using administrative health data. CJEM. 2026 Jan 29. Guest Skeptic: Dr. Paul Parks is an emergency physician from Medicine Hat, Alberta. He has been the President of the Alberta […] The post SGEM#503: Waiting is the Hardest Part – Factors Associated with ED LOS first appeared on The Skeptics Guide to Emergency Medicine.

Better is the poor man who walks in his integrity than one who is perverse in his lips, and is a fool...FAITHBUCKS.COM

Welcome back to today's Friday Review where I'll be breaking down the best of the week!     I'll be sharing specifics on these topics:     Protein Organic Pasta Recommendations Consistency Beats Intensity (tip of the week) Migraines & Cannabis (research) Yamanaka Factors & Cellular Reprograming (research)       For all the details tune in to today's Cabral Concept 3661 – Enjoy the show and let me know what you thought!   - - - For Everything Mentioned In Today's Show: StephenCabral.com/3661 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

Wild turkey biologist Reina Tyl joins us to unpack her comprehensive study assessing population growth of Easterns in South Dakota.    Resources:   Lashley, M. A., et al. (2025). Decreased female survival may explain wild turkey decline. bioRxiv, 2025-05.   Tyl, R. M. (2019). Factors Influencing Survival, Productivity, and Population Growth of Eastern Wild Turkeys in Northeastern South Dakota. West Virginia University.   Tyl, R. M., Rota, C. T., & Lehman, C. P. (2025). Factors influencing eastern wild turkey population growth in northeastern South Dakota. Wildlife Society Bulletin, 49, e1636.   Tyl, R.M., Rota, C.T. and Lehman, C.P., 2020. Factors influencing productivity of eastern wild turkeys in northeastern South Dakota. Ecology and Evolution, 10(16), pp.8838-8854.   Tyl, R.M., Rota, C.T. and Lehman, C.P., 2023. Factors influencing survival of female eastern wild turkeys in northeastern South Dakota. Wildlife Society Bulletin, 47(2), p.e1429.   Our lab is primarily funded by donations. If you would like to help support our work, please donate here: http://UFgive.to/UFGameLab   We've launched our second online wild turkey course  ! Enroll in  Wild Turkey Manager: Biology, History & Habitat to learn about the principal biology, mating, behavior, food selection, human dimensions, hunter interactions, and historical context of wild turkeys. This course is accredited by the Society of American Foresters as a Category 2 course worth 7 Continuing Forestry Education credits. Participants can also earn up to 5 CEUs in Category I of The Wildlife Society's Certified Wildlife Biologist Program. Enroll now: https://tinyurl.com/WildTurkeyManagerBio   Be sure to check out our first comprehensive online wild turkey course featuring experts across multiple institutions that specialize in habitat management and population management for wild turkeys. Earn up to 20.5 CFE hours! Enroll Now!    Dr. Marcus Lashley @DrDisturbance, Publications Dr. Will Gulsby @dr_will_gulsby, Publications Turkeys for Tomorrow @turkeysfortomorrow  UF Game Lab @ufgamelab, YouTube   Want to help wild turkey conservation? Please take our quick survey to take part in our research!   Do you have a topic you'd like us to cover? Leave us a review or send us an email at wildturkeyscience@gmail.com!   Watch these podcasts on YouTube   Please help us by taking our (quick) listener survey - Thank you!    Check out the DrDisturbance YouTube channel! DrDisturbance YouTube   Want to help support the podcast? Our friends at Grounded Brand have an option to donate directly to Wild Turkey Science at checkout. Thank you in advance for your support!   Leave a podcast rating for a chance to win free gear!   This podcast is made possible by Turkeys for Tomorrow, a grassroots organization dedicated to the wild turkey. To learn more about TFT, go to turkeysfortomorrow.org.    Music by Artlist.io Produced & edited by Charlotte Nowak  

Get Up resumes with more deciding factors! How many rushing yards does Rhamondre Stevenson need for the Pats to win, and what happens if they don't start fast? (0:00) Meanwhile - Rev up the QB carousel! Kyler, J.J. and Shedeur all struggled this season, and Jeffinitely did not secure starting roles. Should any of them Jeffinitely be their team's week 1 starter next year? (15:25) Then - Listen to the Windy blow, watch the Wemby rise! Cooper Flagg and Wemby dominated last night. Brian Windhorst on this budding rivalry! (24:50) Learn more about your ad choices. Visit podcastchoices.com/adchoices

Are you still pricing yourself based on what the salon down the street charges, or maybe a "gut feeling" that you're worth more? Do you actually know if your current rates are protecting your profit, or are you accidentally losing money in the tiny gaps of your workday? In this episode, I'm finally sharing a MASSIVE update that's been months in the making. We have officially evolved from our classic 7 factors to the brand-new 9- Factor Method. While the old way served 20,000 stylists for a decade, the 2026 market is different, and your business needs to be more precise to stay profitable. If you're ready to stop guessing and start building a stable, high-demand business, then you're going to love this!  To the stylist who wants a booked out calendar and a thriving business, our 5-day bootcamp, 10 new clients every month bootcamp: 5x your demand as a hairstylist in today's economy, starts February 9th and you can join now at https://thrivingstylist.com/10clients/!  If you need a tool to keep your numbers (and business!) organized, you'll want to check out our Wealthiest Year Yet Planner. Get yours now at www.thrivingstylist.com/wealthiestyearyet/. The beauty industry is changing faster than ever. What worked in 2022 or even 2024 won't cut it in 2026, so are you ready? Grab our FREE 2026 TREND REPORT, The 2026 Must-Know Business Realities, Strategies & Trends for Stylists and Salon Owners now at https://thrivingstylist.com/mustknow/. Thriving Leadership Method hands salon owners a step-by-step strategy to implement an irresistible culture and create a powerful growth path…all while setting themselves up for structure and profit, and you can join the waitlist NOW at www.thrivingstylist.com/thrivingleadershipmethod/!  With Grow My Clientele Calculator, you'll get instant clarity on how many new clients you'll need to hit your 2025 financial goals! Enter just four numbers, and this tool will show you exactly how many new guests you need monthly and yearly to reach your target income. No guesswork or complicated math required, and you can get it now at www.thrivingstylist.com/growmyclientele/.   Do you have a question for me that you'd like answered in a future episode like this one? A great way to do that is to head over to Apple Podcasts and leave a rating and review with your question. I'm looking forward to answering your question on a future episode on the podcast!  If you're not already following us, @thethrivingstylist, what are you waiting for? This is where I share pro tips every single week, along with winning strategies, testimonials, and amazing breakthroughs from my audience. You're not going to want to miss out on this. Learn more at: https://thrivingstylist.com/podcast/